Meningococcal vaccine ACWY (NIMENRIX, Pfizer, Belgium)

Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Meningococcal disease often occurs without warning—even among people who are otherwise healthy. Meningococcal disease can spread from person to person through close contact (coughing or kissing) or lengthy contact, especially among people living in the same household.

NIMENRIX (Meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine) protects against 4 serogroups - A, C, W, and Y:

Anyone can get meningococcal disease but certain people are at increased risk, including:

• Infants younger than one year old

• Adolescents and young adults 16 through 23 years old

• People with certain medical conditions that affect the immune system

• Microbiologists who routinely work with isolates of N. meningitidis

• People at risk because of an outbreak in their community

Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, amputations, nervous system problems, or severe scars from skin grafts.

Find more information about Nimenrix (MenACWY)